Pain Management Drugs Global Market Report 2024

Description

“Pain Management Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pain management drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pain management drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pain management drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Anesthetics; Anticonvulsants; Anti-migraine Agents; Antidepressants; Opioids; Nonnarcotic Analgesics
2) By Indication: Arthritic Pain; Neuropathic Pain; Cancer Pain; Chronic Back Pain; Postoperative Pain; Migraine; Fibromyalgia; Muscle sprain/strain; Bone fracture; Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Novartis AG; Eli Lilly And Company; Abbott Laboratories; Endo International plc; Purdue Pharma L.P.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A pain management drug is a medication designed to reduce pain, achieving analgesia through actions at multiple levels of the nervous system. These actions include the inhibition of neurotransmitter release from the primary afferent terminals in the spinal cord and the activation of descending inhibitory controls in the midbrain.

The primary classes of pain management drugs comprise non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics. NSAIDs, or nonsteroidal anti-inflammatory drugs, are specifically designed to lower a high fever, reduce inflammation, and alleviate discomfort. They find application in various conditions such as arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, fibromyalgia, muscle sprain/strain, bone fractures, among others. These drugs are distributed through different channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The pain management drugs market research report is one of a series of new reports from The Business Research Company that provides pain management drugs market statistics, including pain management drugs industry global market size, regional shares, competitors with a pain management drugs market share, detailed pain management drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the pain management drugs industry. This pain management drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pain management drugs market size has grown strongly in recent years. It will grow from $76.76 billion in 2023 to $81.08 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historical period can be attributed to factors such as the increase in chronic pain cases, a rise in cancer cases, heightened surgical procedures, improved methods of pain assessment, and government initiatives.

The pain management drugs market size is expected to see strong growth in the next few years. It will grow to $100.94 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The anticipated growth in the forecast period can be attributed to the adoption of non-opioid alternatives, the development of targeted therapies, precision medicine approaches, implementation of psychological interventions, and a concentrated effort on minimizing side effects. Key trends expected in the forecast period encompass the adoption of value-based care models, expanded access programs, the exploration of combination therapies, the development of innovative formulations, and the emergence of biosimilar pain drugs.

The anticipated increase in the number of surgeries is poised to drive the growth of the pain management drugs market. Surgical procedures involve medical interventions that cut or penetrate the body's tissues for therapeutic purposes or to enhance bodily functions. Pain management drugs are crucial in surgeries as they help control and alleviate post-operative pain, contributing to improved patient comfort and recovery. In 2021, surgical procedures saw a substantial increase of 54% compared to 2020, with non-surgical procedures also rising by 44%, as reported by the Aesthetic Society. This surge in the rate of surgeries is a significant factor propelling the pain management drugs market.

The growth of the pain management drugs market is further expected to be boosted by the rise in the geriatric population. The geriatric population, comprising individuals aged 65 and older, often requires pain management drugs to alleviate conditions such as arthritis, cancer, and neurological disorders that are more prevalent in later life. According to a report by the World Health Organization (WHO) in October 2022, it is projected that by 2030, one in six individuals globally will be 60 years or older, and the number of individuals over 60 will double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. This demographic shift toward an aging population is a driving force behind the growth of the pain management drugs market.

A key trend gaining traction in the pain management drugs market is technological advancement. Major companies in this market are dedicated to developing innovative technologies to address pain management needs. For example, in November 2021, AppliedVR, Inc., a U.S.-based company offering virtual reality therapeutics, introduced EaseVRx, a prescription-only immersive virtual reality system designed to help patients with chronic lower back pain. Utilizing cognitive behavioral therapy and other behavioral techniques, EaseVRx employs 56 VR sessions over eight weeks to reduce pain and pain interference. This application of behavioral therapy principles through virtual reality represents a notable technological advancement in pain management.

Major companies in the pain management drugs market are developing drugs and obtaining FDA approval. FDA approval, indicating adherence to safety and efficacy standards, is crucial for commercial distribution in the United States. For instance, in October 2023, Hyloris Pharmaceuticals, a Belgium-based pharmaceutical company, received FDA approval for Maxigesic IV. This non-opioid intravenous painkiller, combining paracetamol and ibuprofen, offers a dual-action mechanism for pain relief and represents a significant advancement in the market, providing a new non-opioid treatment option for post-operative pain relief.

In November 2021, Pacira BioSciences, a U.S.-based pharmaceutical company, completed the acquisition of Flexion Therapeutics for $427.5 million. This strategic move strengthens Pacira's position in non-opioid pain management and expands its product portfolio to offer comprehensive non-opioid solutions along the pain pathway. The acquisition includes Flexion's ZILRETTA, an extended-release treatment for osteoarthritis knee pain, along with two clinical-stage pain medication candidates, FX201 and FX301. Flexion Therapeutics, a U.S.-based biopharmaceutical company, has a focus on non-opioid pain management.

Major companies operating in the pain management drugs market report are Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Purdue Pharma L.P., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Baxter International Inc., Sanofi, Medtronic PLC, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Allergan, Daiichi Sankyo Company Limited, Grunenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd

North America was the largest region in the pain management drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pain management drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pain management drug market consists of sales of acetaminophen, anti-seizure medications, steroids, muscle relaxers, and other related drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11212

1. Executive Summary

2. Pain Management Drugs Market Characteristics

3. Pain Management Drugs Market Trends And Strategies

4. Pain Management Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Pain Management Drugs Market Size and Growth

5.1. Global Pain Management Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pain Management Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pain Management Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pain Management Drugs Market Segmentation

6.1. Global Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Anesthetics
Anticonvulsants
Anti-migraine Agents
Antidepressants
Opioids
Nonnarcotic Analgesics
6.2. Global Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Back Pain
Postoperative Pain
Migraine
Fibromyalgia
Muscle sprain/strain
Bone fracture
Other Indications
6.3. Global Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Pain Management Drugs Market Regional And Country Analysis

7.1. Global Pain Management Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pain Management Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pain Management Drugs Market

8.1. Asia-Pacific Pain Management Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pain Management Drugs Market

9.1. China Pain Management Drugs Market Overview
9.2. China Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pain Management Drugs Market

10.1. India Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pain Management Drugs Market

11.1. Japan Pain Management Drugs Market Overview
11.2. Japan Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pain Management Drugs Market

12.1. Australia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pain Management Drugs Market

13.1. Indonesia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pain Management Drugs Market

14.1. South Korea Pain Management Drugs Market Overview
14.2. South Korea Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pain Management Drugs Market

15.1. Western Europe Pain Management Drugs Market Overview
15.2. Western Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pain Management Drugs Market

16.1. UK Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pain Management Drugs Market

17.1. Germany Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pain Management Drugs Market

18.1. France Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pain Management Drugs Market

19.1. Italy Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pain Management Drugs Market

20.1. Spain Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pain Management Drugs Market

21.1. Eastern Europe Pain Management Drugs Market Overview
21.2. Eastern Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pain Management Drugs Market

22.1. Russia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pain Management Drugs Market

23.1. North America Pain Management Drugs Market Overview
23.2. North America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pain Management Drugs Market

24.1. USA Pain Management Drugs Market Overview
24.2. USA Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pain Management Drugs Market

25.1. Canada Pain Management Drugs Market Overview
25.2. Canada Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pain Management Drugs Market

26.1. South America Pain Management Drugs Market Overview
26.2. South America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pain Management Drugs Market

27.1. Brazil Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pain Management Drugs Market

28.1. Middle East Pain Management Drugs Market Overview
28.2. Middle East Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pain Management Drugs Market

29.1. Africa Pain Management Drugs Market Overview
29.2. Africa Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pain Management Drugs Market Competitive Landscape And Company Profiles

30.1. Pain Management Drugs Market Competitive Landscape
30.2. Pain Management Drugs Market Company Profiles
- 30.2.1. Novartis AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Eli Lilly And Company
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Endo International plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Purdue Pharma L.P.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Pain Management Drugs Market Competitive Benchmarking

32. Global Pain Management Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pain Management Drugs Market

34. Pain Management Drugs Market Future Outlook and Potential Analysis

34.1 Pain Management Drugs Market In 2028 - Countries Offering Most New Opportunities
34.2 Pain Management Drugs Market In 2028 - Segments Offering Most New Opportunities
34.3 Pain Management Drugs Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer